Delivery Order SPE2DR25D3005-SPE2DR26FP7TH
- Not listed
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $3,884.63 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 13, 2025, with completion scheduled for November 14, 2025. This non-competitive delivery order represents a firm fixed price transaction sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,441.71 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,812.02 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 25, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and running through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,304.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $9,779.61 on December 4, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-competitive delivery order executed without set-aside designation, with performance to be completed by December 5, 2025. The work will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,373.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a $17,326.95 delivery order contract to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.999 billion ceiling value through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $4,161.86 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on December 18, 2025, with completion expected by December 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,787.56 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on November 12, 2025, with completion targeted for November 13, 2025. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The product...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7THDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,159.04 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This is a firm fixed-price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999.9 billion and extending through December 2026. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting AmerisourceBergen's established role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. As the prime contractor under the SPE2DX vehicle, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare programs. This delivery order represents a routine execution of the company's established contract obligations to meet operational pharmaceutical needs within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 12/2/25 |